CLLSMICRO

Cellectis S.A.

HealthcareBiotechnology
$2.83
$0.00(-2.08%)
52W$1.42
$5.48
Updated Jun 29, 02:00 AM
RSI37
RS Rating15/99
Beta1.82
Volatility96%
F-Score3/9
Mkt Cap$284M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Cellectis S.A. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 15), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (96% annualized), which requires wider risk management.

Relative Strength
15
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.82
vs S&P 500
HIGH BETA
52W Position
35%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.56
50 SMA > 100 SMA$3.59
100 SMA > 150 SMA$3.91
150 SMA > 200 SMA$3.82

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.07-7.74%BELOW
50 SMA$3.56-20.41%BELOW
100 SMA$3.59-21.22%BELOW
150 SMA$3.91-27.54%BELOW
200 SMA$3.82-25.87%BELOW

Price Performance

1D-2.1%
1W+0.4%
1M-22.9%
3M-11.3%
6M-40.4%
YTD-41.0%
1Y+89.9%
3Y+16.7%
52-Week Trading Range35% from low
$2.83
52W Low$1.42
52W High$5.48

Technical Indicators

RSI (14)BEARISH
36.8
305070
Setup ScoreCOOL
3/10
Base depth: 62.2%

Risk Profile

Beta
1.82
52W Vol
96%
ATR
$0.17
Max DD (1Y)
-48%

Volume Analysis

Today
8.4K
50D Avg
35.9K
Vol Ratio
0.23x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+14%
$-0.24
Q3'25+103%
$0.01
Q4'25-556%
$-0.27
Q1'26
$-0.18
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+2.86%
5 Years:+7.40%
3 Years:+56.12%
TTM:+42.95%

Compounded Profit Growth

10 Years:-0.45%
5 Years:
3 Years:
TTM:-8.45%

Stock Price CAGR

10 Years:-19.68%
5 Years:-29.51%
3 Years:+16.71%
1 Year:+89.93%

Return on Equity

10Y Avg:-42.5%
5Y Avg:-59.2%
3Y Avg:-65.1%
Last Year:-80.7%

Key Metrics

Market Cap$284M
Gross Margin86.6%
Net Margin-92.7%
Piotroski F-Score3/9

Frequently Asked Questions

Is CLLS in an uptrend right now?

CLLS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is CLLS overbought or oversold?

CLLS's RSI (14) is 37. The stock is in neutral territory, neither overbought nor oversold.

Is CLLS outperforming the market?

CLLS has a Relative Strength (RS) Rating of 15 out of 99. CLLS is currently lagging the broader market.

Where is CLLS in its 52-week range?

CLLS is trading at $2.83, which is 52% of its 52-week high ($5.48) and 35% above its 52-week low ($1.42).

How volatile is CLLS?

CLLS has a Beta of 1.82 and 52-week volatility of 96%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.